天弘基金
Search documents
1/5财经夜宵:得知基金净值排名及选基策略,赶紧告知大家
Sou Hu Cai Jing· 2026-01-05 15:44
Core Viewpoint - The article provides an objective ranking of open-end fund net values, highlighting the top-performing and underperforming funds based on their recent net value changes [1]. Fund Performance Summary Top 10 Funds by Net Value Growth - The top-performing funds over the past five days include: 1. Huayin Health Life Theme Flexible Allocation: 1.2860, +11.83% 2. Bank of China Health Life Mixed: 2.6160, +10.33% 3. Founder Fubon Core Advantage Mixed A: 1.2438, +10.02% 4. Founder Fubon Core Advantage Mixed C: 1.2276, +10.01% 5. Yongying Pioneer Semiconductor Intelligent Selection Mixed A: 1.4573, +9.27% 6. Yongying Pioneer Semiconductor Intelligent Selection Mixed C: 1.4548, +9.26% 7. Great Wall Consumption Value Mixed A: 1.2019, +8.66% 8. Great Wall Consumption Value Mixed C: 1.1853, +8.64% 9. Dongfang Alpha Technology Intelligent Selection Mixed A: 1.1577, +8.44% 10. Dongfang Alpha Technology Intelligent Selection Mixed C: 1.1568, +8.44% [2]. Bottom 10 Funds by Net Value Growth - The underperforming funds over the past five days include: 1. Huabao Overseas New Energy Vehicle Stock Initiation A: 1.7237, -1.63% 2. Huabao Overseas New Energy Vehicle Stock Initiation C: 1.7070, -1.63% 3. Morgan China Century Mixed (QDII) RMB: 1.9771, -1.48% 4. Tianhong Global High-end Manufacturing Mixed C: 1.8463, -1.46% 5. Tianhong Global High-end Manufacturing Mixed A: 1.8609, -1.46% 6. Chuangjin Hexin Global Pharmaceutical Biotechnology Stock Initiation C: 1.7003, -1.39% 7. Chuangjin Hexin Global Pharmaceutical Biotechnology Stock Initiation A: 1.7162, -1.38% 8. Invesco Great Wall Global Semiconductor Chip Stock A (QDII-LOF): 1.9794, -1.25% 9. Invesco Great Wall Global Semiconductor Chip Stock C (QDII-LOF): 1.9565, -1.25% 10. Jiashi Global Industry Upgrade Stock Initiation C: 2.5437, -1.23% [3][4]. Market Analysis - The Shanghai Composite Index opened high and showed a strong upward trend, closing with a significant increase. The total trading volume reached 2.56 trillion, with a market breadth of 4185 gainers to 1169 losers. The leading sectors included insurance, healthcare, internet, and semiconductors, all rising over 4% [6]. - Notable concepts that surged included brain engineering, blood oxygen monitors, and cloud gaming, each increasing over 5%. Conversely, the sectors that lagged included oil, hotel and catering, and public transportation [6]. Fund Holdings and Concentration Huayin Health Life Theme Fund - The fund has a high concentration of holdings at 60.58%, with significant positions in: 1. United Imaging Healthcare: 5.81% 2. Yirui Technology: 6.51% 3. Mindray Medical: 4.80% 4. BGI Genomics: 5.09% 5. MicroPort Scientific: 8.77% 6. Tianzhihang: 10.66% 7. Other notable holdings include Kai Li Medical and Weicheng Medical, both showing substantial growth [8]. Huabao Overseas New Energy Vehicle Fund - This fund has a higher concentration of 75.42%, with major holdings in: 1. NIO Inc.: 9.89% 2. NVIDIA Corporation: 9.71% 3. Ferrari: 9.23% 4. Tesla Inc.: 8.34% 5. Broadcom Inc.: 7.98% 6. Other significant positions include Carvana and Pony.ai, with notable fluctuations in value [8].
开门红!中国资产大涨,逾千只股票ETF同频上涨
券商中国· 2026-01-05 11:57
Core Viewpoint - The A-share market experienced a strong start in 2026, with the Shanghai Composite Index returning to 4000 points, driven by significant gains in technology sectors such as brain-computer interfaces, semiconductors, and pharmaceuticals [1][2] Market Performance - On January 5, 2026, the A-share market saw the Shanghai Composite Index rise over 2%, with the ChiNext Index and the Sci-Tech Innovation Index also showing strong performance [2] - The brain-computer interface index recorded nearly a 10% increase, while medical device and memory chip indices rose over 6% [2] - More than 1000 stock ETFs rose in tandem, with over 90% of all stock ETFs experiencing gains, particularly in the semiconductor and pharmaceutical sectors [2][4] ETF Trends - 35 ETFs related to semiconductors and pharmaceuticals saw gains exceeding 5%, with some medical device ETFs rising over 6% [2] - The top-performing ETF was the China-Korea Semiconductor ETF, which increased by 8.46% [3] - Cross-border ETFs also performed well, with over 90% of 185 ETFs rising, particularly those tracking the Hong Kong medical and pharmaceutical indices [3] Fund Flows and Investment Trends - In 2025, the total net inflow into ETFs exceeded 1.16 trillion yuan, with over 620 billion yuan directed towards industry-themed ETFs, particularly in AI and innovative pharmaceuticals [6] - The Hong Kong market saw significant inflows, with over 250 billion yuan into ETFs, especially those related to the Hang Seng Technology Index and medical sectors [6] Future Outlook - Analysts suggest that 2026 will focus on embracing technology growth and upstream cycles, with expectations of a slow bull market driven by stable growth policies and improving corporate earnings [7][8] - Key sectors for investment include renewable energy, chemicals, construction materials, and innovative pharmaceuticals, with a particular emphasis on AI applications and semiconductor advancements [8]
每一年都为基民赚钱真的很难吗?这只年年正收益,年化回报8.7%的基金值得一看|1分钟了解一只吾股好基(七十三)
市值风云· 2026-01-05 10:05
近10年每年都在稳定赚钱的基金。 作者 | 市值风云基金研究部 编辑 | 小白 过去10年每年都能跑出正收益的基金可谓凤毛麟角,天弘通利混合A(000573.OF)是其中一个。 2014年3月14日成立,目前合并规模为11.8亿,成立以来净值增长167.4%,大幅跑赢业绩基准,并跑 赢同期沪深300指数50个百分点。 天弘通利混合A的业绩比较基准是三年期银行定期存款利率(税后)+0.75%,在大盘走牛的阶段,该 只基金收益率进攻性有限,2019-2020年均大幅跑输沪深300指数,但在熊市中优势凸显,尤其是在20 高比例配置股票资产,在2022-23年市场走熊的时间里,该只基金表现还算不错,两年均维持了正收 益,对基金经理选股是一种考验。 22-23年跑出超额。 该只基金成立以来年化回报达到8.7%。回撤方面,在2022年以前最大回撤控制在5%以内,最近3年最 大回撤在15%左右。 2024年基金收益率有一定的进攻性以及2022年以后动态回撤幅度较此前加大,是由于基金策略从此前 的固收+逐步转向加大权益中枢。 2022年一季度开始天弘通利混合A逐渐降低了债券配置权重,从85%逐步下降,2023年中报以后该比 ...
天天基金2025年度社区榜单正式揭晓!
天天基金网· 2026-01-05 07:46
] 基金有风险 投资需谨慎 广告 25年度社区榜单乡 n 同心相伴行致远,智启财富赴新程 年度热门讨论榜 年度影响力牛人 年度暖心陪伴榜 0 在天天基金社区,我们一同走过了2025年的四季轮转。无数个平凡的日子里,正因有各位创作者与 机构伙伴的真诚分享、深度解读与温暖互动,才让这里始终闪耀着思想的火花与陪伴的温度。 这一年,我们见证了坚持的价值,也收获了共同成长的喜悦。为感谢每一份用心输出,天天基金社 区从内容质量、互动频率、用户反响等多个维度综合评选,正式发布2025年度六大榜单:年度暖心 陪伴榜、年度热门讨论榜、年度优质互动经理人、年度社区热门圈友、年度涨粉先锋以及年度影响 力牛人。这份榜单,是我们对所有同行者的一份致敬。 现在,让我们一起揭晓天天基金2025年度社区榜单,认识这些始终陪伴在我们投资路上的引路人与 同行者。 一、 年度暖心陪伴榜 持续分享投资策略,与投资者相伴而行,他们是: 华夏基金、国泰基金、易方达基金、华宝基金、鹏华基金、银华基金、永赢基金、富国基金管理有 限公司、信达澳亚基金、博时基金、创金合信基金、广发基金、景顺长城基金、招商基金、工银瑞 信基金、建信基金、汇添富基金、嘉实基金、中 ...
天天基金2025年度基金直播榜单揭晓!
天天基金网· 2026-01-05 07:46
基金直播的 "流量担当" 是它们! 2025年基金直播圈的 "年度成绩单" 新鲜落地!天天基金2025年度直播荣耀排行正式揭晓! 谁是基金直播的顶流机构? 哪家的直播互动能让你 "聊到停不下来"? 哪位主播凭实力圈粉无数?现在给 你划重点 【直播影响力榜】 大 外 型 天弘基金 ke see was and and the sering to the sering to the sering to the sering to the sering to the sering to the sering to the ser 方正富邦基金 招商基金 永赢基金 同泰基金 VIC 中航基金 万家基金 东财基金 腿华基金 信达澳亚基金 汇添富基金 长信基金 喜实基金 「评选标准」 统计区间: 2025.1.1-12.15 影响力: 按照观看次数 (30%)、平均观看时长 (20%) 、点赞 量 (20%) 、关联交易量 (30%),进行加总计算排名。 【 直 播 互 动 人 气 榜 】 哪 家 直 播 能 让 你 " 聊 到 上 头 " ? { 长信基金 } {工银瑞信基金} { 南方基金} 博时基金 银布基金 民生 ...
港股通央企红利ETF天弘(159281)涨0.41%,成交额4281.43万元
Xin Lang Cai Jing· 2026-01-05 07:10
Core Insights - The Tianhong CSI Hong Kong Stock Connect Central State-Owned Enterprises Dividend ETF (159281) closed up 0.41% on January 5, with a trading volume of 42.81 million yuan [1] - The fund was established on August 20, 2025, with an annual management fee of 0.50% and a custody fee of 0.10% [1] - As of December 31, the fund's latest share count was 354 million shares, with a total size of 350 million yuan, indicating no change in share count or size year-to-date [1] Fund Performance - The current fund manager is He Yuxuan, who has managed the fund since its inception, with a return of -0.81% during the management period [2] - The fund's top holdings include COSCO Shipping Holdings, Orient Overseas International, China National Foreign Trade Transportation Group, PetroChina, CITIC Bank, CNOOC, China Shenhua Energy, People's Insurance Company of China, China Unicom, and Agricultural Bank of China, with respective holding percentages [2] Liquidity and Trading Activity - Over the last 20 trading days, the cumulative trading amount for the fund was 531 million yuan, with an average daily trading amount of 26.56 million yuan [1]
2025场外指数基金成绩单出炉!天弘通信设备斩获同类第一!
Sou Hu Cai Jing· 2026-01-05 06:59
Core Insights - The Tianhong CSI All-Share Communication Equipment Index Fund (Class A: 020899, Class C: 020900) achieved remarkable performance in 2025, ranking first among similar index funds with Class A shares yielding 118.64% and Class C shares yielding 118.21%, significantly outperforming the average return of passive index funds during the same period [1][2]. Fund Performance - The performance data for the Tianhong CSI All-Share Communication Equipment Index Fund covers the period from January 1, 2025, to December 31, 2025, with the fund's Class A shares achieving a return of 118.64% and Class C shares achieving a return of 118.21% [1]. - The fund closely tracks the CSI All-Share Communication Equipment Index, which includes 50 listed companies involved in the communication equipment sector, reflecting the overall performance of these companies [6]. Investment Strategy - Zhang Ge, the fund manager, emphasizes the dual trends of "AI computing power explosion + communication infrastructure upgrade" as the core opportunities in the technology market for 2025, which underpins the recommendation to focus on the communication equipment sector [2][3]. - The demand for computing power is expected to grow exponentially due to the transition of AI from a technical concept to large-scale implementation, with communication equipment serving as the "transmission base" [2]. - The industry is experiencing a "volume and price increase" pattern, with leading manufacturers seeing revenue growth rates exceeding 50%, and some even surpassing 150%, providing solid support for the fund's performance [2]. Market Positioning - Since June 2025, Zhang Ge has consistently recommended the Tianhong CSI All-Share Communication Equipment Index Fund through his personal Alipay account, indicating a proactive approach to investment opportunities in the communication equipment sector [3].
突破“芯”高度!科创芯片设计ETF天弘(认购代码:589073)今日正式首发!
Sou Hu Cai Jing· 2026-01-05 02:36
Group 1 - The Tianhong STAR Market Chip Design ETF (code: 589070) was officially launched on January 5, 2023, aiming to track the performance of quality listed companies in the chip design sector on the STAR Market [1] - The fund selects securities from listed companies involved in chip design to reflect the overall performance of this sector [1] - The Chinese chip design industry is projected to grow significantly, with the number of companies increasing from 1,380 in 2017 to 3,901 by 2025, representing a compound annual growth rate (CAGR) of 14% [2] Group 2 - The sales revenue of Chinese chip design companies is expected to rise from 194.6 billion yuan in 2017 to 646 billion yuan in 2024, with a CAGR of 19%, outpacing the global semiconductor sales growth of 6% during the same period [2] - Dongwu Securities anticipates that leading domestic computing chip companies will enter a performance realization phase by 2026, particularly benefiting from the expansion of advanced GPU production capacity [2] - Donghai Securities highlights that the semiconductor industry is experiencing structural high growth, driven by demand from AI servers, smart wearables, and new energy vehicles, while supply constraints in storage chips are expected to persist [3]
我武生物股价涨5.4%,天弘基金旗下1只基金重仓,持有2.04万股浮盈赚取3.12万元
Xin Lang Cai Jing· 2026-01-05 02:30
Group 1 - The core point of the news is that I-Wu Biotech's stock price increased by 5.4% to 29.88 CNY per share, with a total market capitalization of 15.645 billion CNY as of the report date [1] - I-Wu Biotech, established on September 19, 2002, and listed on January 21, 2014, specializes in the research, production, and sales of products for the diagnosis and treatment of allergic diseases [1] - The company's main revenue sources include dust mite drops (94.17%), Artemisia flower (4.35%), skin prick liquid (1.31%), R&D services (0.12%), and others (0.05%) [1] Group 2 - Tianhong Fund has a significant holding in I-Wu Biotech, with the Tianhong National Bio-Medical ETF holding 20,400 shares, representing 0.05% of the fund's net value, ranking as the ninth largest holding [2] - The Tianhong National Bio-Medical ETF, established on January 27, 2021, has a current size of 224 million CNY and has achieved a year-to-date return of 6.03%, ranking 3691 out of 4189 in its category [2] - The fund manager, He Yuxuan, has been in position for 4 years and 190 days, with the fund's total assets amounting to 9.413 billion CNY, achieving a best return of 101.32% and a worst return of -62.42% during the tenure [3]
华虹公司股价涨5.5%,天弘基金旗下1只基金重仓,持有1.18万股浮盈赚取6.97万元
Xin Lang Cai Jing· 2026-01-05 02:01
Group 1 - The core viewpoint of the news is that Huahong Semiconductor has shown a significant increase in stock price, reflecting positive market sentiment and investor interest [1] - As of January 5, Huahong's stock price rose by 5.5% to 113.80 CNY per share, with a trading volume of 477 million CNY and a turnover rate of 1.04%, resulting in a total market capitalization of 197.55 billion CNY [1] - Huahong Semiconductor, established on January 21, 2005, specializes in wafer foundry services with a focus on specialty processes, including embedded/non-volatile memory, power devices, analog and power management, and logic/RF [1] Group 2 - Tianhong Fund has a significant position in Huahong Semiconductor, with its Tianhong SSE Sci-Tech Innovation Board 100 Index Enhanced Fund (021385) increasing its holdings by 282 shares to a total of 11,800 shares, representing 2.87% of the fund's net value [2] - The Tianhong fund has achieved a year-to-date return of 51.7%, ranking 585 out of 4189 in its category, and has a total fund size of 18.464 million CNY [2] - The fund manager, Lin Xinlong, has a tenure of 5 years and 40 days, with the fund's total assets amounting to 25.391 billion CNY and a best return of 123.41% during his management [3]